Watch IVF. Know when insiders buy.
One email the day a filing lands. Free.
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $2.2M | +16.7% | 97.2% | −$1.3M | $889K | — | 0.35 | −$1.1M | — | — | Aug 14 |
| Q1 2026 · Mar 31 | $2M | +23.1% | 99.7% | −$1.6M | −$5.5M | — | -3.38 | −$1.9M | — | — | Aug 14 |
| Q4 2025 · Dec 31derived | $1.6M | −6.1% | — | −$1.4M | $1.1M | — | 472.78 | $25K | $12K | $13K | Jun 2 |
| Q3 2025 · Sep 30 | $1.8M | +22.6% | — | −$1.6M | −$3.4M | — | -39.40 | −$1.8M | $8K | −$1.8M | Jun 2 |
| Q2 2025 · Jun 30 | $1.9M | +1.5% | 99.8% | −$3M | −$3.6M | — | -364.23 | −$1.7M | $9K | −$1.7M | Aug 14 |
| Q1 2025 · Mar 31 | $1.6M | +3.9% | 35.0% | −$1.2M | −$17.4M | — | -3473.93 | −$3.5M | $15K | −$3.6M | Aug 14 |
| Q4 2024 · Dec 31derived | $1.7M | +22.0% | 39.7% | −$2M | −$3.8M | — | -3723.77 | −$617K | $79K | −$696K | Jun 2 |
| Q3 2024 · Sep 30 | $1.4M | +47.0% | 31.0% | −$1.3M | −$1.6M | — | -15.11 | −$641K | $0 | −$641K | Nov 17 |
| Q2 2024 · Jun 30 | $1.8M | — | 53.1% | −$1.9M | −$2.2M | — | -22.39 | −$1.5M | $55K | −$1.5M | Nov 17 |
| Q1 2024 · Mar 31 | $1.6M | — | 45.3% | −$1.5M | −$1.6M | — | -7.55 | −$261K | $50K | −$310K | Nov 17 |
| Q4 2023 · Dec 31derived | $1.4M | — | 33.0% | −$1.5M | −$2M | — | -61.61 | −$715K | $75K | −$790K | Apr 30 |
| Q3 2023 · Sep 30 | $975K | — | 40.4% | −$886K | −$1.2M | — | -0.70 | −$1.2M | $108K | −$1.4M | Nov 19 |
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $6.8M | 99.6% | −$7.2M | −$23.3M | -340.9% | -214.64 | −$7M | $43K | −$7.1M | — | — |
| FY2024 · to Dec 31 | $6.5M | 43.1% | −$6.6M | −$9.3M | -141.7% | -3782.65 | −$3M | $184K | −$3.2M | — | — |
| FY2023 · to Dec 31 | $3M | 34.7% | −$6.8M | −$8M | -266.0% | -67.37 | −$4.8M | $445K | −$5.2M | — | — |
| FY2022 · to Dec 31 | $822K | 59.7% | −$10.6M | −$10.9M | -1324.8% | -17.97 | −$6.6M | $11K | −$6.6M | — | — |
| FY2021 · to Dec 31 | $4.2M | 96.5% | −$5.2M | −$6.7M | -160.0% | -0.63 | −$6M | $416K | −$6.4M | — | — |
| FY2020 · to Dec 31 | $1M | 91.4% | −$5.5M | −$8.3M | -804.7% | -1.52 | −$4.8M | $49K | −$4.8M | — | — |
Every number comes from INVO Fertility, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.